stars 1 stars 2 stars 3

Bayhill Therapeutics is a clinical-stage biopharmaceutical company using its proprietary therapeutic BHT-DNA™ platform to develop a pipeline of novel products to treat autoimmune diseases in a fundamentally new manner. The Company's product candidates are designed to restore the immune system to its normal state known as "tolerance," by selectively eliminating specific, harmful immune responses while leaving the rest of the immune system intact. Through a targeted and selective approach, Bayhill's product candidates have the potential to improve efficacy, safety and tolerability relative to current therapies. The immune system is the major biological defense responsible for fighting pathogens and tumors by recognizing certain molecules, known as antigens. Antigens are defined as any substance that invokes the production of a specific immune response. These include proteins like MBP and proinsulin, and specific peptides that are fragments of those proteins. A properly functioning immune system attacks foreign antigens but is tolerant to self-antigens, which are antigens present in the body's own tissues. Autoimmune diseases occur when there is a breakdown of the mechanism responsible for tolerance that triggers the immune system to mediate an immune response against the body's own tissues. This inability to fend off this self directed autoimmune attack results in a chronic, debilitating disease characterized by tissue destruction. Major diseases for which there is a known autoimmune component include multiple sclerosis (MS), type 1 diabetes mellitus (T1D), myasthenia gravis (MG), and inflammatory bowel disease (IBD). Antigen-specific autoimmune responses to a self-antigen are considered the primary drivers of these diseases. Effective treatments that specifically disrupt this self-antigen response with minimal side effects could potentially address the fundamental cause of an autoimmune disease while leaving the broader immune system intact. The key components of immune response are lymphocytes, or specialized ...

Bayhill Therapeutics Inc. Questions

The Bayhill Therapeutics Inc. annual revenue was $5.6 million in 2026.

Bayhill Therapeutics Inc. is based in Palo Alto, California.

The NAICS codes for Bayhill Therapeutics Inc. are [32541, 3254, 32, 325].

The SIC codes for Bayhill Therapeutics Inc. are [28, 283].

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Spring 2026 G2 Best Est ROI Mid Market Spring 2026 G2 Easiest Admin Mid Market Spring 2026 G2 Most Implementable Spring 2026 G2 Best Results Mid Market Spring 2026 G2 Lead Capture Mid Market Spring 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users